5-Alpha Reductase 2 as a Marker of Resistance to 5ARI Therapy

Clinical trial NCT04288427 · RECRUITING

Trial details

NCT number: NCT04288427
Sponsor: Beth Israel Deaconess Medical Center
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Benign Prostatic Hyperplasia Prostate Hyperplasia Prostate Disease Prostate Hypertrophy Prostate Pain Lower Urinary Tract Symptoms Urinary Obstruction Urinary Tract Disease

Start date: 2020-09-25
Primary completion: 2026-06-30
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.